OccuLogix Looks to Tears, Hopes to Survive Difficulties
OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose confidence in the company and […]
news1
Maryland Medicaid Approves ActiPatch Technology for Kidney Compromised Patients
Patients with kidney disease often avoid common pain relievers like aspirin, ibuprofen and naproxen. These medications have the potential to exacerbate existing conditions and create […]
Boston Scientific to Acquire CryoCor
Boston Scientific will acquire CryoCor for $17.6 million in cash or $1.35 per share. The buyout comes after a tumultuous year for the San Diego-based […]
Cancer Researchers See the Light: Caliper Life Sciences Intruduces Bioware Ultra
Five cancer cells were injected subcutaneously into the dorsal region near the thigh of mouse. Tumor growth is monitored weekly by an IVIS Spectrum. The […]
AngioDynamics Offers to Purchase Diomed Assets
AngioDynamics and Diomed, who once sat on opposing sides of the courtroom, have found occasion to work together, though only after Diomed filed for bankruptcy. […]
Nanogen Strengthens Active Partnering and Licensing Program
Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to the Research Market As the biomedical industry works to gain a better understanding […]
AngioDyanics Rebounds on Third Quarter Results
In March I reported that the market may have overreacted to AngioDynamics’ revision of its full year guidance; the company predicted full year sales in […]
CMS Decision Creates Huge New Opportunity for INRatio
The human body has a complex mechanism that causes blood to clot if a wound occurs – a desirable response under normal circumstances. But under […]
Encision Strives to Enlarge Customer Base; Will Investors Get Burned?
Boulder, CO-based Encision offers electrosurgical devices and laparoscopic instruments that incorporate active electrode monitoring or AEM. The technology continuously shields and monitors monopolar laparoscopic instruments […]
[Video Profile] Interview with Craig Davenport, President & CEO of Endocare
Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and […]